P3 HEALTH PARTNERS INC (PIII) Stock Price, Quote, News and Overview
NASDAQ:PIII - Nasdaq - US7444131053 - Common Stock - Currency: USD
PIII Quote, Performance and Key Statistics
NASDAQ:PIII (5/1/2025, 9:24:53 PM)
8.87
-0.12 (-1.33%)
The current stock price of PIII is 8.87 USD. In the past month the price decreased by -3.27%. In the past year, price decreased by -72.27%.
PIII Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 12.26 | 90.87B | ||
| CVS | CVS HEALTH CORP | 12.81 | 87.67B | ||
| LH | LABCORP HOLDINGS INC | 16.38 | 20.19B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.29 | 19.79B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 13.52 | 14.68B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 116.78 | 11.24B | ||
| DVA | DAVITA INC | 14.78 | 11.24B | ||
| CHE | CHEMED CORP | 24.34 | 8.38B | ||
| HIMS | HIMS & HERS HEALTH INC | 66.96 | 8.03B | ||
| GH | GUARDANT HEALTH INC | N/A | 6.03B | ||
| CRVL | CORVEL CORP | 26.07 | 5.60B | ||
| OPCH | OPTION CARE HEALTH INC | 23.65 | 5.28B |
Related stock screener links
About PIII
Company Profile
P3 Health Partners Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Chicago, Illinois and currently employs 360 full-time employees. The company went IPO on 2021-02-10. P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The firm supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. The company has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.
Company Info
P3 HEALTH PARTNERS INC
2045 W Grand Ave Ste B, Pmb # 82152
Chicago ILLINOIS US
Employees: 400
Company Website: https://ir.p3hp.org/
Investor Relations: https://ir.p3hp.org/
Phone: 13128228897
P3 HEALTH PARTNERS INC / PIII FAQ
What is the stock price of P3 HEALTH PARTNERS INC today?
The current stock price of PIII is 8.87 USD. The price decreased by -1.33% in the last trading session.
What is the ticker symbol for P3 HEALTH PARTNERS INC stock?
The exchange symbol of P3 HEALTH PARTNERS INC is PIII and it is listed on the Nasdaq exchange.
On which exchange is PIII stock listed?
PIII stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for P3 HEALTH PARTNERS INC stock?
11 analysts have analysed PIII and the average price target is 28.05 USD. This implies a price increase of 216.23% is expected in the next year compared to the current price of 8.87. Check the P3 HEALTH PARTNERS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is P3 HEALTH PARTNERS INC worth?
P3 HEALTH PARTNERS INC (PIII) has a market capitalization of 63.69M USD. This makes PIII a Micro Cap stock.
How many employees does P3 HEALTH PARTNERS INC have?
P3 HEALTH PARTNERS INC (PIII) currently has 400 employees.
What are the support and resistance levels for P3 HEALTH PARTNERS INC (PIII) stock?
P3 HEALTH PARTNERS INC (PIII) has a resistance level at 9.25. Check the full technical report for a detailed analysis of PIII support and resistance levels.
Is P3 HEALTH PARTNERS INC (PIII) expected to grow?
The Revenue of P3 HEALTH PARTNERS INC (PIII) is expected to decline by -6.63% in the next year. Check the estimates tab for more information on the PIII EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy P3 HEALTH PARTNERS INC (PIII) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PIII, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PIII, evaluating the profitability, health, valuation and growth aspects
- P3 HEALTH PARTNERS INC (PIII) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- P3 HEALTH PARTNERS INC (PIII) Sales and EPS estimates to see what analysts future expectations are.
- P3 HEALTH PARTNERS INC (PIII) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- P3 HEALTH PARTNERS INC (PIII) Insider and Institutional Ownership to learn about the owners and their transactions.
- P3 HEALTH PARTNERS INC (PIII) Stock Chart to make your own analysis
- P3 HEALTH PARTNERS INC (PIII) Latest news and press-releases to stay up to date.
Does P3 HEALTH PARTNERS INC (PIII) stock pay dividends?
PIII does not pay a dividend.
When does P3 HEALTH PARTNERS INC (PIII) report earnings?
P3 HEALTH PARTNERS INC (PIII) will report earnings on 2025-05-07.
What is the Price/Earnings (PE) ratio of P3 HEALTH PARTNERS INC (PIII)?
P3 HEALTH PARTNERS INC (PIII) does not have a PE ratio as the earnings reported over the last twelve months were negative (-34.25).
PIII Technical Analysis
PIII Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to PIII. Both the profitability and financial health of PIII have multiple concerns.
PIII Financial Highlights
Over the last trailing twelve months PIII reported a non-GAAP Earnings per Share(EPS) of -34.25. The EPS decreased by -5169.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.34% | ||
| ROE | -178.9% | ||
| Debt/Equity | 1.18 |
PIII Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to PIII. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 27.78% and a revenue growth -6.63% for PIII